Anderton B H, Brion J P, Couck A M, Davis D R, Gallo J M, Hanger D P, Ladhani K, Latimer D A, Lewis C, Lovestone S
Department of Neuroscience, Institute of Psychiatry, London, United Kingdom.
Neurobiol Aging. 1995 May-Jun;16(3):389-97; discussion 398-402. doi: 10.1016/0197-4580(94)00160-3.
Two cellular systems have been used to investigate the modulation of tau hyperphosphorylation. In the first system, the effects of the excitatory amino acid glutamate, the microtubule destabilising agent colchicine, and beta 25-35-amyloid peptide on tau phosphorylation were studied in rat cortical neurones in primary culture. Using immunocytochemistry and western blot analysis, we demonstrated that tau in these cultures is normally highly phosphorylated, but a proportion becomes rapidly dephosphorylated following treatment of the cultures with glutamate or colchicine. These changes in tau phosphorylation occurred prior to cell death. In the second system, the ability of p42 MAP and p44 MAP kinases, glycogen synthase kinases 3 alpha and 3 beta (GSK-3 alpha and GSK-3 beta) to phosphorylate tau in transfected COS cells was investigated. Both GSK-3 alpha and GSK-3 beta phosphorylated tau to produce a PHF-like state of phosphorylation but the MAP kinases failed to induce such a transformation in tau. These results suggest that aberrant regulation of GSK-3 alpha/beta may be a pathogenic mechanism in Alzheimer's disease.
已使用两种细胞系统来研究tau蛋白过度磷酸化的调节。在第一个系统中,在原代培养的大鼠皮质神经元中研究了兴奋性氨基酸谷氨酸、微管解聚剂秋水仙碱和β25 - 35淀粉样肽对tau蛋白磷酸化的影响。通过免疫细胞化学和蛋白质印迹分析,我们证明这些培养物中的tau蛋白通常高度磷酸化,但在用谷氨酸或秋水仙碱处理培养物后,一部分tau蛋白会迅速去磷酸化。tau蛋白磷酸化的这些变化发生在细胞死亡之前。在第二个系统中,研究了p42丝裂原活化蛋白激酶(MAP)和p44 MAP激酶、糖原合酶激酶3α和3β(GSK - 3α和GSK - 3β)在转染的COS细胞中使tau蛋白磷酸化的能力。GSK - 3α和GSK - 3β都使tau蛋白磷酸化,产生类似成对螺旋丝(PHF)的磷酸化状态,但MAP激酶未能诱导tau蛋白发生这种转变。这些结果表明,GSK - 3α/β的异常调节可能是阿尔茨海默病的致病机制。